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Abstract
Sweat test is the standard for cystic fibrosis (CF) diagnosis. Conductivity is an alternative method not yet approved, in spite
of its good correlation with chloride concentration. The aim was to assess the capacity of sweat conductivity to discriminate
between CF and non-CF subjects. Automated measurements of conductivity and chloride concentration were carried out on the
same sweat samples from subjects with clinical suspicion of CF. Sweat samples from 3834 subjects, median age 1.8 years (range
1 month–54 years) were analysed, and those with chloride titration )60 mmolyl were considered as CF patients (ns294).
Conductivity median values in CF and non-CF subjects were 111 mmolyl (82–148) and 36 mmolyl (12–89), respectively. The
Spearman correlation between chloride titration and conductivity was rs0.60 (P-0.001). The receiver operating characteristics
(ROC) curve showed very high agreement between two methods. The best conductivity cut-off value to diagnose CF was G90
mmolyl (sensitivity 99.7%, specificity 100%, positive and negative predictive values of 100% and 99.97%, respectively, and
kappas0.998). Likewise, the best conductivity cut-off value to exclude CF was -75 mmolyl. The sweat conductivity method
showed good correlation with chloride titration, and accurately discriminated between subjects with and without CF. In accordance
with this, CF diagnosis might be confirmed for conductivity values G90 mmolyl and excluded for -75 mmolyl. Values between
75 and 89 mmolyl should correspond to an equivocal range. However, more studies are needed to confirm the role of conductivity
in definitive CF diagnosis.
 2002 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
Keywords: Cystic fibrosis; Conductivity; Chloride titration
1. Introduction
Diagnostic criteria for cystic fibrosis (CF) are based
on the presence of clinical phenotypic features of the
disease and the evidence of a dysfunctional cystic
fibrosis transmembrane regulator (CFTR). The CFTR
abnormality can be demonstrated by identification of
mutations in both alleles of the CF gene, increased nasal
potential difference, or elevated sweat electrolyte con-
centration w1x. Currently, the sweat test is the most
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widely used and most conclusive biochemical method
to diagnose CF, inasmuch as over 99% of subjects
homozygous for the CF gene have sweat chloride and
sodium concentrations above 60 and 70 mmolyl, respec-
tively w2x.
Measurement of sweat chloride concentration by the
quantitative pilocarpine iontophoresis test (QPIT), as
described by Gibson and Cooke w3x, is considered to be
the most accurate method to diagnose CF and has been
accepted as the standard for sweat testing w4,5x. How-
ever, this method involves multiple steps for collection
and analysis of the sweat sample, is cumbersome to
perform, and involves the risk of volumetric, gravimet-
ric, condensate and evaporation errors in the procedure,
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especially in laboratories that do not perform sweat
testing routinely.
Alternative methods have been introduced in recent
years w6–8x to simplify both the collection and analysis
of sweat samples. In this context, the measurement of
sweat conductivity is an increasingly used method
because it is easier to perform and requires a smaller
sample (minimum of 6 ml) than the QPIT. Although
some studies have shown that the conductivity method
correlates well with chloride concentration w9–11x, it is
still not accepted by the National Committee for Clinical
Laboratory Standards (NCCLS) as a definitive diagnos-
tic tool, and the Cystic Fibrosis Foundation relegates it
to the status of a ‘screening’ method w4,5x. According
to their consensus, subjects with sweat conductivity
G50 mmolyl should be referred for a quantitative sweat
chloride test (QPIT) w5x.
The aim of the present study was to evaluate, in a
large number of subjects with clinical suspicion of CF,
the efficacy of the conductivity method to discriminate
those subjects with a sweat chloride concentration )60
mmolyl (as measured in a chloride titrator), thus assess-
ing its accuracy as a diagnostic analytical procedure.
2. Materials and methods
2.1. Subjects
This study was carried out on subjects attending the
laboratory of the Mexican Cystic Fibrosis Association
from January 1990 to December 2000. In this period, a
total of 7933 sweat samples were processed for the
diagnosis of CF, from which 3834 (48.3%) (from a
similar number of subjects) were submitted to both
chloride titration and conductivity analysis. The remain-
ing 4099 samples were excluded either because only
one method was performed (2972 samples), or they
represented repeated analyses (587 samples), or because
insufficient sweat was obtained to perform even the less
demanding method, the conductivity assay, which
required a minimum of 6–15 ml (540 samples). Most
subjects with insufficient sweat sample were neonates.
There was no prior selection of patients for inclusion
in the study, either on clinical or genotypic grounds. All
subjects were referred by public or private healthcare
providers from all around the country because of a
clinical suspicion of CF, including chronic respiratory
symptoms (85.5%), failure to thrive or malnutrition
(54.3%), steatorrhea or malabsorption (34.5%), family
history of CF (14.1%), meconium ileus or other intes-
tinal obstruction (7.6%), hydric and electrolyte dysequi-
librium (5.9%), positive neonatal screening test (0.6%),
and other causes (5.6%), such as prolonged jaundice,
biliary cirrhosis, hypoalbuminaemia, HIV infection and
Bartter pseudosyndrome.
For the purpose of the study, a CF diagnosis was
considered to be established when chloride concentration
was )60 mmolyl in a sweat sample. However, all those
subjects with a positive result were submitted to a
second chloride titration and a further clinical, laboratory
or genetic analysis in order to corroborate the CF
diagnosis. Although two false-positive cases were
detected by these methods, in the present study they
were still considered as CF patients according to the
above-mentioned criterion. Where two or more sweat
tests were done from the same subject, only the first
study with results from both methods were used for
statistical analysis.
2.2. Sweat collection
In all cases, two-stage sweat sample collection was
accomplished using the Macroduct system (Wescor
Inc, Logan, Utah). In the first phase (iontophoretic
stimulation) the forearm skin was cleaned with deioni-
zed water and strong drying. Two electrodes holding
pilocarpine-containing disks (2.8-cm-diameter disk of
solid agar containing 0.5% pilocarpine nitrate in 96%
water) were attached to the skin with straps. The
electrodes were connected to a current source system
operated by batteries that deliver a maximum current of
1.5 mA during a 5-min period. In the second phase
(sweat collection) the skin was cleaned and dried, and
a Macroduct collector was placed over the area where
the positive electrode was located. The Macroduct
collector is a disposable, concave plastic disk with a
0.025-inch hole in the centre, to which a spiral plastic
tube of ;85 ml in total capacity is attached. Sweat
travels through the hole and is captured in the plastic
tube, in which no dead space or evaporation exists. A
small quantity of blue water-soluble dye (10 nmol) on
the concave disk surface, which does not interfere with
the assay of sweat electrolytes, allows the visualisation
of sweat in the plastic tube. Sweat was collected during
30 min, sufficient time to collect approximately 50–60
ml. This volume was sufficient to perform both methods
(conductivity followed by chloride titration) on the same
sweat sample.
2.3. Conductivity method
The sweat sample was analysed in a 3100 Sweat-
Chek analyser (Wescor Inc), which was calibrated on a
daily basis with a 90 mmolyl NaCl solution according
to the manufacturer’s instructions. The minimum amount
of sweat sample required by the equipment is 6–15 ml,
although in our study all samples consisted of at least
50 ml (in order to be able to subsequently perform the
chloride titration). Controls were run using either cus-
tom-made reference solutions (10 and 100 mmolyl
NaCl) or solutions provided by the manufacturer (40,
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Fig. 1. Relationship between results obtained with the conductivity
method and chloride titration in a chloridimeter in sweat samples from
3834 subjects with (closed circles) or without (open circles) cystic
fibrosis (chloride )60 mmolyl). r , Spearman correlation coefficient.S
70 and 130 mmolyl NaCl). After each reading, deioni-
zed water and air were passed through the conductivity
cell of the Sweat-Chek in order to remove any remaining
sweat and prevent contamination of the next sample.
Conductivity is expressed as mmolyl throughout this
paper. This is an abbreviation of mmolyl (equivalent
NaCl), a unit that represents the molar concentration of
a solution of sodium chloride that has the same conduc-
tivity as the sweat sample at the same temperature. It is
emphasised that this value does not in any way represent
the actual sodium or chloride concentration in the sweat
sample.
2.4. Chloride titration
Determination of the sweat chloride concentration
was accomplished using a CMT 10 chloride titrator
(Radiometer Corp, Copenhagen, Denmark). This equip-
ment is designed to measure the chloride concentration
in undiluted microsamples and is based on the coulo-
metric titration principle. Detection limits of this titrator
are 0–999 mmolyl Cl (steps of 1 mmolyl) with any
accuracy of "0.5 mmolyl ("0.5%) and repeatability
of -;0.5%. Calibration of the equipment was carried
out on a daily basis using 1 and 50 mmolyl Cly
solutions.
The sweat sample collected after conductivity was
transferred into a sealed container, which was weighed
on a digital analytical balance (model HI60, Sartorius,
Gottingen, Germany) to corroborate that a sample of at
least 50 mg (approx. equivalent to 50 ml) was obtained.
The sample was then transferred to the titration vessel
of the CMT10 chloride titrator. Low (10 mmolyl Cl )y
and high (100 mmolyl Cl ) controls were processedy
along with the titration of each sweat sample. Control
and calibration solutions were stored in glass containers
at 4 8C, brought to room temperature before use, and
were renewed every 3 months according to NCCLS
guidelines.
2.5. Data analysis
Because conductivity and chloride titration values did
not follow a normal distribution in the total population
or in most population subjects, a non-parametric
approach was used for data evaluation. The Mann–
Whitney U test was applied for pairwise group compar-
isons, and global association of both methods was
assessed through Spearman’s correlation coefficient (r ).S
The capability of the conductivity test to discriminate
between CF and non-CF subjects was assessed by
constructing a receiver operating characteristic (ROC)
curve, and overall accuracy of the best cut-off values
was assessed through calculation of sensitivity, specific-
ity, positive predictive value (PPV), negative predictive
value (NPV) and kappa coefficient. Finally, the absolute
difference or bias between both methods, as well as the
chloride titrationyconductivity ratio, was also calculated.
Statistical significance was set at two-tailed P-0.05.
3. Results
A total of 3834 subjects (45.5% females) aged 1
month–54 years (median 1.8 years) were included in
the study. From this population, 294 subjects (7.7%)
had CF according to a positive ()60 mmolyl) chloride
titration result, whereas 94 (2.5%) had equivocal values
(40–60 mmolyl). CF subjects (51.4% females) had a
median age of 2.5 years, ranging from 1 month to 28
years.
Correlation analysis between the two diagnostic meth-
ods (including the 3834 subjects) yielded r s0.60 (P-S
10 ; Fig. 1). Table 1 shows the results obtained withy6
the conductivity method in subjects grouped according
to the presence of the disease and gender. As expected,
conductivity values for CF patients were much higher
than those observed in non-CF subjects (P-0.0005)
and male subjects had lower values than females (P-
0.005). As can be observed in Fig. 2, the frequency
distribution of conductivity values in CF and non-CF
subjects illustrates that both populations are clearly
separated from each other.
A very large area under the curve was found in the
ROC curve (Fig. 3), demonstrating that the conductivity
method closely matched the chloride titration. In this
sense, the best conductivity cut-off value able to predict
a positive CF diagnosis (as assessed by a chloride
titration )60 mmolyl) was 90 mmolyl or greater, with
99.66% sensitivity, 100% specificity, 100% PPV and
99.97% NPV, and with a kappa value of 0.998 (Table
2). Likewise, the best conductivity cut-off value able to
predict a negative CF diagnosis was -75 mmolyl, with
99.25% sensitivity, 93.37% specificity, 99.28% PPV and
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Table 1
Conductivity (mmolyl) values in the population studied
Non-CF subjects CF subjects
Female Male All Female Male All
(ns1592) (ns1948) (ns3540) (ns151) (ns143) (ns294)
Median 37 34* 36 114† 108*,† 111†
Minimum 17 12 12 90 82 82
Maximum 88 89 89 142 148 148
P-0.005 compared with the respective female group.*
P-0.0005 compared with the respective non-CF group.†
Fig. 2. Frequency distribution of conductivity values in subjects with (closed bars) or without (open bars) diagnosis of cystic fibrosis (chloride
)60 mmolyl).
93.12% NPV, reaching a kappa value of 0.925 (Table
3).
The bias (i.e. the conductivity minus the chloride
titration) had a median value of 26 mmolyl (range
y3–63) in CF patients, higher than among non-CF
subjects (21 mmolyl, range y5–65, P-0.0001). The
correlation between chloride titration and bias in the CF
subjects (r sy0.64, P-10 ) showed that the highery6S
the chloride titration value, the lower the bias, whereas
this relationship was not clearly present among non-CF
patients (r sy0.05, Ps0.002) (Fig. 4). Finally, as canS
be observed in Fig. 5, the chloride titrationyconductivity
ratio showed a linear relationship when plotted against
chloride titration in both CF (r s0.80, P-10 ) andy6S
non-CF (r s0.72, P-10 ) subjects. No CF patienty6S
had a chloride titrationyconductivity ratio lower than
0.5.
4. Discussion
The main result from our study was to demonstrate
that the conductivity method possesses very high capac-
ity to identify CF and non-CF subjects (sweat chloride
)60 mmolyl or -40 mmolyl, respectively). Thus, if
further studies confirm our results, this method might
become a definitive and reliable diagnostic analytical
procedure for CF. In this sense, a conductivity value
G90 mmolyl should be considered confirmatory of the
disease, a value -75 mmolyl should be viewed as
negative, and values from 75 to 89 mmolyl correspond
to the equivocal range.
The sweat conductivity method is increasingly used
by many laboratories to diagnose CF. Recently, a survey
conducted by LeGrys w12x in 809 institutions found that
over 45% used the sweat conductivity method. This
5J.L. Lezana et al. / Journal of Cystic Fibrosis 2 (2003) 1–7
Fig. 3. Receiver operating characteristics curve obtained in 3834 sub-
jects, assessing the capacity of conductivity to predict cystic fibrosis
diagnosis (chloride titration )60 mmolyl). Each circle represents a
different conductivity cut-off value. The inset shows the complete
range of conductivity cut-off values (1–150 mmolyl), while the main
panel is a close-up of those cut-off values that achieved better per-
formance, ranging from 94 (left lower corner) to 77 mmolyl (right
upper corner). The closed circle shows the best conductivity cut off
value (G90 mmolyl), which yields 99.66% sensitivity without false
positive results.
Table 2
Capacity of different conductivity cut-off values to predict CF diagnosis (chloride )60 mmolyl), according to the number of patients correctly
diagnosed
Conductivity Chloride titration decision Sensitivity Specificity PPV NPV Kappa
cut-off value
Diagnose CF Non-diagnose CFa
(%) (%) (%) (%)
(mmolyl)
(ns294) (ns3540)
G92 291 3540 98.98 100.00 100.00 99.92 0.994
G91 292 3540 99.32 100.00 100.00 99.94 0.996
G90b 293 3540 99.66 100.00 100.00 99.97 0.998
G89 293 3539 99.66 99.97 99.66 99.97 0.996
G88 293 3535 99.66 99.86 98.32 99.97 0.989
PPV, positive predictive value; NPV, negative predictive value.
Includes subjects with negative (-40 mmolyl Cl ) and equivocal values (40–60 mmolyl Cl ).a y y
Best cut-off value.b
Fig. 4. Relationship between chloride titration value and bias (con-
ductivity minus chloride titration) among subjects with (closed cir-
cles) or without (open circles) cystic fibrosis.
Table 3
Capacity of different conductivity cut-off values to exclude CF diagnosis (chloride -40 mmolyl), according to the number of subjects correctly
excluded
Conductivity Chloride titration decision Sensitivity Specificity PPV NPV Kappa
cut-off value
Exclude CF Non-exclude CFa
(%) (%) (%) (%)
(mmolyl)
(ns3457) (ns377)
-85 3451 302 99.83 80.11 97.87 98.05 0.870
-80 3445 329 99.65 87.27 98.63 96.48 0.908
-75b 3431 352 99.25 93.37 99.28 93.12 0.925
-70 3418 362 98.87 96.02 99.56 90.27 0.923
-65 3364 373 97.31 98.94 99.88 80.04 0.871
PPV, positive predictive value; NPV, negative predictive value.
Includes subjects with positive ()60 mmolyl Cl ) and equivocal values (40–60 mmolyl Cl ).a y y
Best cut-off value.b
preference rate seems to be justified because the con-
ductivity method is easier to perform than the traditional
chloride concentration by QPIT. Nevertheless, up to now
the conductivity method has not been accepted by the
Cystic Fibrosis Foundation or the NCCLS as a definitive
diagnostic method for this disease w4,5x, in spite of the
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Fig. 5. Relationship between chloride titration result and the chloride
titrationyconductivity ratio in subjects with (closed circles) or without
(open circles) cystic fibrosis.
good agreement between conductivity and chloride titra-
tion found in several studies. Sanchez et al. w10x studied
14 CF and 60 non-CF Chilean children, and found that
conductivity was highly correlated (rs0.98) with Naq
plus K concentration. This study showed that all CFq
children had conductivity values G98 mmolyl, and the
authors suggested 50–60 mmolyl as doubtful conductiv-
ity values deserving repetition of the test. In the USA,
Hammond et al. w9x described the relationship between
conductivity values and Cl concentration in sweaty
samples from 471 subjects and 43 CF patients. They
found a high correlation coefficient (rs0.97), with all
CF patients having G90 mmolyl in the conductivity
determination. Heeley et al. w11x analysed 57 CF and
154 non-CF infants and children in the United Kingdom,
and concluded that sweat conductivity is as effective as
chloride measurements in the laboratory diagnosis of
CF. They suggested conductivity values from 67 to 71
mmolyl as the limits of the equivocal range. On the
other hand, Van der Merwe et al. w13x, in South Africa,
studied sweat samples obtained once a week for 5
consecutive weeks from 15 healthy adults, 20 healthy
infants and 20 CF patients. They found that calculated
95% ranges for conductivity values in healthy babies
and CF patients were 18–60 and 96–144 mmolyl,
respectively, and suggested that any result between 60
and 90 mmolyl must be repeated using a definitive
method.
In our study we corroborated the good agreement
between conductivity and chloride titration. The corre-
lation coefficient between both assays was apparently
lower (r s0.60) than expected, which is explained byS
the use of a non-parametric correlation due to the non-
normal distribution of our population. If the parametric
Pearson correlation had been used, it would have yielded
an r value of 0.92, which is similar to the r values
obtained in the above-mentioned studies. More impor-
tant than the correlation itself is the different approach
we used in order to assess whether the conductivity
method can be viewed as a diagnostic tool. In this
context, all statistical tests that evaluate this issue (ROC
curve, sensitivity, specificity, predictive values, kappa
test) clearly indicated that the conductivity method has
an excellent capacity to discriminate between CF and
non-CF subjects (according to chloride sweat concentra-
tion )60 mmolyl), and thus yields a high degree of
diagnostic accuracy.
It is interesting to note that frequency distributions of
conductivity values found in CF and non-CF subjects
were similar to that observed by Shwachman and Mah-
moodian in 1967 w14x for chloride concentration, which
suggests that both methods are diagnostically equivalent.
The bias we found in our data had larger dispersion
than that reported by Hammond et al. w9x. Thus, among
CF subjects the bias decreased as the chloride titration
result increased, while in non-CF subjects a large dis-
persion of bias values was always present, independently
of the chloride titration result. Although this is an
interesting finding requiring more research, this varia-
bility did not influence the results obtained through the
evaluation of specific cut-off points. Because conductiv-
ity assesses the total ions present in the sweat sample,
mainly Cl , Na and K , but also lower amounts ofy q q
bicarbonate, lactate, calcium, magnesium, sulfate and
phosphate, the chloride titrationyconductivity ratio
should represent the proportion of chloride in the sweat
sample, with respect to total ions. In this sense, we
found that the chloride proportion in CF patients was
always higher than 50%, and thus a chlorideyconductiv-
ity ratio less than 50% accurately excluded a CF
diagnosis. This finding agrees with the observation by
Slegers w15x that the ratio of NayCl concentrations
appears to be greater than 1.0 in sweat from non-CF
subjects, while it is almost always less than 1.0 in CF
patients. The assessment of the chlorideytotal ion ratio
is interesting enough to warrant further exploration of
its potential usefulness as screening tool in CF.
Until now there has been an apparent lack of consen-
sus regarding the validity of sweat conductivity methods
to confirm or exclude the diagnosis of CF. According to
the Cystic Fibrosis Foundation, a patient having a
conductivity result G50 mmolyl should be referred for
a quantitative sweat chloride analysis (QPIT) w5x, while
the manufacturer of the Sweat Chek (Wescor) recom-
mends that conductivity results-60 mmolyl are normal
and )80 mmolyl are positive for CF w16x. Our results
demonstrated that even narrower intervals can be set for
the conductivity method to diagnose or exclude CF.
Thus, according to our data, a sweat conductivity value
G90 mmolyl might be considered confirmatory of the
disease, a value -75 mmolyl should be viewed as a
normal result, and values ranging from 75 to 89 mmoly
l should correspond to equivocal values and the subject
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submitted for further studies. Suggested actions to follow
after the first conductivity test would be similar to those
recommended for QPIT w1x. Thus, individuals with
phenotypic features of CF and equivocal values in sweat
conductivity method should be submitted to a second
sweat test (either with conductivity or chloride titration),
mutation analysis andyor determination of the ion trans-
port across the nasal epithelium. An initial positive
conductivity method should be repeated on a different
day and, if positive again, the CF diagnosis would be
confirmed.
It is interesting to note that the conductivity method
also reflected the changes observed in subjects with
borderline chloride titration values. In this sense, from
the 94 subjects with a first chloride titration within the
equivocal range (40–60 mmolyl) two changed to posi-
tive values in the second chloride titration test, five
persisted with equivocal values, and the remaining 87
changed to negative values. Conductivity catalogued
these 94 subjects (plus eight additional subjects) as
within the equivocal range (75–89 mmolyl) too, and
all changes occurring in them in the second chloride
titration were also detected by conductivity.
In conclusion, our study carried out on a large number
of subjects suggests that conductivity might be as
reliable as quantitative sweat chloride analysis to diag-
nose or exclude CF, and thus its potential as a definitive
diagnostic tool for CF should be considered. Ideally, our
results should be reproduced in different collection sites,
sweat rates and clinical contexts (e.g. newborn screening
programs, adult and paediatric clinics), and confirmed
by prospective multicentre studies in which both meth-
ods are evaluated in subjects with a definitive diagnosis
of CF.
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